The boom in using GLP-1 drugs like Ozempic to treat obesity has resulted in a bust regarding the drugs' original purpose, which was to treat Type 2 diabetes, a new study finds.

A new report based on national prescription data shows weight-loss drug use is rising among kids and teens. GLP-1 medications, like Ozempic and Wegovy, are drugs originally developed to treat ...

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent years, a new study says.

There has been a notable uptick in GLP-1 use since 2020, Rezaie noted. The U.S. Food and Drug Administration approved semaglutide for use as a weight-loss drug in 2021.

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

ITHACA, NY. — Consumers using GLP-1 weight-loss drugs reduce their grocery spending nearly 6% on average, with notable decreases in purchases of sweet and salty foods and snacks, a study by ...

CHICAGO -- In patients with type 2 diabetes and obesity, use of GLP-1 receptor agonists was associated with a lower risk of obesity-related cancers and death from any cause, a target trial ...

Eli Lilly announced successful results from its phase 3 trial of Orforglipron, the first-ever GLP-1, once-daily oral pill for weight loss and type 2 diabetes management.

Strategic opportunities for brands and retailers While GLP-1 use may be temporary, the mindset shift is likely long-term.